NCT00537615View on ClinicalTrials.gov

An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

October 31, 2007

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

PD 0332334

Trial Locations (1)

06511-5473

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY